Sarepta Therapeutics (SRPT) EBITDA Margin (2010 - 2026)
Sarepta Therapeutics (SRPT) reported EBITDA Margin of 5.91% for Q2 2026, down 14.78 percentage points from 20.69% a year earlier and down 44.59 percentage points from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Sarepta Therapeutics' EBITDA Margin came in at -4.99%, down 6.61 percentage points year-over-year; for FY2025, it was -29.81%, down 43.26 percentage points from FY2024.
- EBITDA Margin has a five-year change of +69.66 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 13.45% in FY2024 (+31.42 pp), -17.97% in FY2023 (+35.01 pp), -52.98% in FY2022 (+7.10 pp) and -60.08% in FY2021 (+39.39 pp).
- Five-year quarterly EBITDA Margin spans a low of -91.74% in Q4 2025 and a high of 50.50% in Q1 2026.
- Year over year, EBITDA Margin gained in four of the last eight quarters, with an average year-over-year change of -9.43 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2026 (a gain of 89.48 percentage points); the low point was Q4 2025 (a drop of 117.88 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 50.50% (Q1 2026), -91.74% (Q4 2025) and -21.27% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Sarepta Therapeutics | 1.99 Bn | -1.25 Bn | 251.87 Mn | 5.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91% |
| Mar 31, 2026 | 50.50% |
| Dec 31, 2025 | -91.74% |
| Sep 30, 2025 | -21.27% |
| Jun 30, 2025 | 20.69% |
| Mar 31, 2025 | -38.99% |
| Dec 31, 2024 | 26.14% |
| Sep 30, 2024 | 6.85% |
| Jun 30, 2024 | 2.21% |
| Mar 31, 2024 | 10.56% |
| Dec 31, 2023 | 9.07% |
| Sep 30, 2023 | -2.99% |
| Jun 30, 2023 | -46.98% |
| Mar 31, 2023 | -50.01% |
| Dec 31, 2022 | -37.26% |
| Sep 30, 2022 | -52.40% |
| Jun 30, 2022 | -86.19% |
| Mar 31, 2022 | -36.12% |
| Dec 31, 2021 | -47.49% |
| Sep 30, 2021 | -12.65% |
API Access
Sarepta Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();